Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Sees Significant Increase in Short Interest

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 11,896,551 shares, an increase of 147.0% from the January 15th total of 4,815,523 shares. Based on an average daily trading volume, of 20 shares, the days-to-cover ratio is presently 594,827.6 days. Based on an average daily trading volume, of 20 shares, the days-to-cover ratio is presently 594,827.6 days.

Genomma Lab Internacional Stock Performance

Shares of GNMLF stock remained flat at $1.00 during trading on Friday. The company had a trading volume of 116,930 shares, compared to its average volume of 100. Genomma Lab Internacional has a 1-year low of $0.93 and a 1-year high of $1.43. The business has a fifty day moving average price of $1.03 and a two-hundred day moving average price of $1.06.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.